Related Experiment Video
Updated: Jul 15, 2026

Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
Gain-of-glycosylation mutations
Guillaume Vogt1, Benoît Vogt, Nadia Chuzhanova
1Laboratory of Human Genetics of Infectious Diseases, INSERM, U550, Paris 75015, France. vogt@necker.fr
Abstract:
Disease-causing missense (and other in-frame) mutations can exert their deleterious effects at the cellular level through multiple mechanisms. A pathogenic mechanism involves the addition of a novel N-linked glycan. Up to 1.4% of known disease-causing missense mutations are predicted to give rise to gains-of-glycosylation. For some of these mutations, the novel glycans have been shown to be both necessary and sufficient to account for the deleterious impact of the mutation. The chemical complementation of cells from patients in vitro with various modifiers of glycosylation has been demonstrated and raises the possibility of specific chemical treatments for patients bearing gain-of-glycosylation mutations.
Insights
Certain mutations add new N-linked glycans, causing disease. These glycosylation gains are necessary and sufficient for harm, suggesting potential chemical treatments for patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Missense mutations are a significant cause of genetic disorders.
- Novel N-linked glycosylation (NLG) is an emerging pathogenic mechanism for mutations.
- Approximately 1.4% of missense mutations may lead to gain-of-glycosylation (GofG).
Purpose of the Study:
- To investigate the role of GofG in disease pathogenesis.
- To explore the potential for therapeutic interventions targeting glycosylation.
Main Methods:
- Analysis of predicted GofG mutations.
- In vitro chemical complementation assays using patient-derived cells.
- Assessment of glycosylation modifiers as therapeutic agents.
Main Results:
- Gain-of-N-linked glycosylation is a validated pathogenic mechanism for certain mutations.
- Novel glycans can be both necessary and sufficient for the deleterious effects of mutations.
- In vitro studies show that modulating glycosylation can rescue cellular defects.
Conclusions:
- Gain-of-glycosylation mutations represent a distinct class of genetic defects.
- Targeting aberrant glycosylation pathways offers a promising therapeutic strategy for affected individuals.
- Chemical modulation of glycosylation holds potential for treating diseases caused by GofG mutations.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
